Novolog (Pharm-Up 1966) Ltd (TLV: NVLG)

Novolog (Pharm-Up 1966) Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	974	726	1,409	1,504	1,423	783
Market Cap Growth	-15.32%	-48.50%	-6.30%	5.66%	81.80%	100.06%
Enterprise Value	953	674	1,470	1,449	1,385	664
Last Close Price	1.91	1.35	2.60	2.72	2.75	1.50
PE Ratio	-	-	29.66	35.54	35.52	77.22
Forward PE	-	14.02	14.02	14.02	14.02	14.02
PS Ratio	0.56	0.44	0.93	1.20	1.26	0.78
PB Ratio	2.58	1.83	3.03	3.50	4.81	2.97
P/TBV Ratio	11.66	10.37	13.19	9.06	19.23	14.99
P/FCF Ratio	22.10	5.62	22.31	28.51	43.30	10.24
P/OCF Ratio	7.40	3.63	10.62	18.03	24.33	7.72
EV/Sales Ratio	0.55	0.41	0.98	1.15	1.22	0.66
EV/EBITDA Ratio	6.12	5.42	15.60	15.81	17.28	10.80
EV/EBIT Ratio	14.51	12.50	18.90	20.87	24.07	16.56
EV/FCF Ratio	21.62	5.23	23.28	27.46	42.13	8.68
Debt / Equity Ratio	0.52	0.54	0.46	0.39	0.52	0.60
Debt / EBITDA Ratio	1.27	1.46	1.86	1.55	1.62	2.04
Debt / FCF Ratio	4.61	1.67	3.37	3.16	4.69	2.07
Asset Turnover	0.56	0.63	0.64	0.56	0.52	0.52
Inventory Turnover	5.54	6.74	7.07	4.98	4.26	4.56
Quick Ratio	0.83	0.84	0.87	0.91	0.84	0.85
Current Ratio	0.97	0.96	0.98	1.03	0.99	0.98
Return on Equity (ROE)	-1.00%	-9.15%	11.38%	12.35%	14.50%	5.48%
Return on Assets (ROA)	1.41%	1.29%	2.06%	1.94%	1.66%	1.29%
Return on Capital (ROIC)	6.93%	5.24%	7.63%	8.29%	8.25%	9.47%
Earnings Yield	-0.79%	-5.79%	3.37%	2.81%	2.82%	1.29%
FCF Yield	5.74%	17.78%	4.48%	3.51%	2.31%	9.76%
Dividend Yield	2.05%	2.17%	2.53%	3.44%	0.94%	2.86%
Payout Ratio	0.00%	-	67.14%	75.62%	29.95%	152.86%
Buyback Yield / Dilution	0.33%	0.94%	-0.14%	-9.08%	-22.06%	-10.54%
Total Shareholder Return	2.38%	3.12%	2.39%	-5.64%	-21.12%	-7.67%

Source: S&P Capital IQ. Standard template. Financial Sources.